Overview

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of an aqueous nasal spray investigational compound GW685698X compared to placebo on the hypothalamic pituitary adrenocortical (HPA) axis system in children 2 to 11 years of age with perennial allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline